Search Results 231-240 of 17301 for Proto-oncogene
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...
Learn about these malignant brain tumors that happen most often in babies and young children. Treatments include surgery, radiation therapy and ...
[ALK]/ c-ros oncogene 1 [ROS1]) per National Comprehensive Cancer Network (NCCN) guidelines, participant has also been previously treated with or is ...
An additional validated oncogenic driver in MTC if known that could cause resistance to selpercatinib treatment. Examples include, but are not limited to ...
The Proteases in Cancer Lab of Evette S. Radisky, Ph.D., at Mayo Clinic is developing mesotrypsin inhibitors for preclinical models of breast cancer, ...
Four cores in the Mayo Clinic Ovarian Cancer SPORE provide vital help with administration, clinical trials, biospecimens, statistics and research models.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Biomarkers from circulating cell-free tumor DNA in peripheral blood will identify patients with metastatic prostate cancer diagnosed with C11 choline PET/CT who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.